Deciphera Pharmaceuticals (DCPH) Prices 3.18M Share Common Offering at $55/Sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. QGEN

Go back to Deciphera Pharmaceuticals (DCPH) Prices 3.18M Share Common Offering at $55/Sh

Deciphera Pharmaceuticals (DCPH) Announces FDA Acceptance of NDA and Priority Review for Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

February 12, 2020 4:41 PM EST

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its New Drug Application (NDA) seeking approval for ripretinib, the Companys investigational broad-spectrum KIT and PDGFR inhibitor, for the treatment of patients with... More

Deciphera Pharmaceuticals (DCPH) to Offer $250M in Stock

February 12, 2020 4:15 PM EST

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) announced the commencement of a registered underwritten public offering of $250.0 million in shares of its common stock. In addition, Deciphera intends to grant the underwriters a 30-day option to purchase up to $37.5 million in shares of its... More